Drug-specific modulation of motility in Chlamydomonas mutants | ARCADIA FyloGraph | FyloGraph

Fylo›ARCADIA›Graph

InferenceChain·arcadia

Drug-specific modulation of motility in Chlamydomonas mutants

This chain integrates reasoning about how different small molecules differentially impact motility phenotypes in various Chlamydomonas mutant strains and wild-type, reflecting mutation-specific drug responsiveness and species-specific pathway differences.

Confidence

90%

◑partialactivecomplexity: mid

Reasoning Steps (3)

Mutation-specific drug responsivenessStep 1

Species differences in motility regulationStep 2

Assay-dependent drug effect observationsStep 3

Source

Synthesis for current paper

Connections (5)

Drugs affect motility in mutant and wild-type ChlamydomonasAssociation

ATP increases motility in wild-type ChlamydomonasAssociation

Various compounds rescue motility in mutant strainsAssociation

Species differences in motility regulation observedAssociation

C. reinhardtii is a valid model for motility defects in SPGFAssociation